Loss narrowed 60.3% but operating cash turned negative as debtors swelled

Operating cash flow swung from +$0.4m in HY23 to -$0.0m in HY24, while trade debtors rose 95.7% to $1.0m and debtor days climbed to 37.9 — above Annolyse's historical baseline range of 21.6–32.9 days (mean 28.7). Cash and equivalents fell 55.4% to $3.9m.

Revenue rose 11.4% to $4.8m, but that growth sits at the lower edge of the supplied historical range (10.2%–28.1%, mean 21.2%). The reported loss narrowed 60.3%, from -$1.7m to -$0.7m at both PBT and NPAT lines, with no tax distortion (effective tax rate 0.0% in both periods). The group remains debt-free; total equity slipped 3.0% to $10.2m and total assets fell to $12.0m, below the historical range of $12.4m–$14.8m.

• Trade debtors grew $0.5m while revenue grew $0.5m, meaning essentially all the period's incremental sales sat in receivables at balance date. Debtor days jumped 16.3 days year-on-year to 37.9, the highest in the supplied baseline. This matters because it converts a narrowing P&L loss into a wider cash outflow and raises the question of whether revenue growth is being supported by extended terms or end-of-period billing concentration.

• Cash runway is the binding constraint. With $3.9m of cash, no debt, and a half-year operating outflow of $0.0m once working capital is included (free cash flow pre-lease -$0.1m), the business is funding the strategy reset from a shrinking cash pile. The 55.4% year-on-year cash decline is larger than the operating outflow alone implies, indicating prior-period investing or financing draws as well.

• Top-line growth has decelerated against the company's own recent track record. Revenue growth of 11.4% is 9.8 percentage points below the historical mean of 21.2%. The B2B-led strategy reset is still producing growth, but at the lower end of what the business has previously delivered.

The supplied second-half shape is therefore the only forward anchor: HY23 represented just 41.9% of FY23 revenue, and the FY23 NPAT loss of -$1.35m was actually smaller than the HY23 loss of -$1.7m, implying a profitable 2H23 of around +$0.3m on the supplied shape. If that pattern repeats, HY24's -$0.7m loss could be substantially recovered in 2H24.

The release does not support claims about full-year break-even. It does support a read that the prior year was second-half weighted on both revenue and profit, so an HY24-only run-rate annualisation ($9.6m) likely understates the full-year outcome.

PBT and NPAT moved identically (gap 0.0pp) with no tax effect, so the headline 60.3% loss reduction is a clean operating read rather than a tax-rate artefact. However, FCF-to-NPAT conversion of 18.5% — and the swing from positive to negative operating cash — shows the income statement is running ahead of the cash statement.

The working-capital story is the swing factor. Operating working capital rose $0.5m, driven almost entirely by receivables; inventory days actually fell slightly (-1.4 days). Capex was modest at 1.8% of revenue, so this is not a capex-funded growth story. The improvement in ROE (from -16.1% to -6.6%) reflects narrower losses on a slightly smaller equity base, not a step-change in capital efficiency.

The durable part of the result is the lower cost base implied by the smaller loss on similar revenue. The less durable part is the cash position, which has eroded materially and is being further pressured by receivables build.

This briefing cannot assess customer-level receivables ageing, gross margin trajectory, or any cost-base detail because none are disclosed in the supplied release.